PharmAust CEO's sayanora triggers stock plunge
Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of its CEO, Dr. Michael Thurn.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MLN | Ann: MLN weekly NAV per share calculation - ANZAC day | 08:32 | 0 | 18 | |||
|
|||||||
MLN | Ann: MLN NAV as at 16/4/24 - $1.0409 | 18/04/24 | 0 | 28 | |||
|
|||||||
MLN | Ann: MLN - Notice of acquisition of securities - 17 April 2024 | 18/04/24 | 0 | 24 | |||
|
|||||||
MLN | Ann: MLN - March 2024 Quarterly Newsletter | 17/04/24 | 0 | 23 | |||
|
|||||||
MLN | Ann: MLN - Notice of acquisition of securities -16 April 2024 | 17/04/24 | 0 | 26 | |||
|
|||||||
MLN | Ann: MLN NAV as at 9/4/24 - $1.0611 | 11/04/24 | 0 | 52 | |||
|
|||||||
MLN | Ann: MLN - Notice of acquisition of securities - 9 April 2024 | 10/04/24 | 0 | 36 | |||
|
|||||||
MLN | Ann: MLN - Notice of acquisition of securities - 8 April 2024 | 09/04/24 | 0 | 23 | |||
|
See All Discussions